Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""treatment resistant"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 8977
Tytuł:
Inappropriate study inclusion in meta-analysis of sham-controlled rTMS for treatment-resistant depression.
Autorzy:
Kennedy KP; Department of Psychiatry, UCLA Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, USA.
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2024 Apr 02; Vol. 24 (1), pp. 247. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Meta-Analysis; Letter
MeSH Terms:
Depression*
Depressive Disorder, Treatment-Resistant*/therapy
Humans ; Treatment Outcome ; Transcranial Magnetic Stimulation ; Double-Blind Method ; Randomized Controlled Trials as Topic
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The clinical effectiveness of a self-management intervention for patients with persistent depressive disorder and their partners/caregivers: results from a multicenter, pragmatic randomized controlled trial.
Autorzy:
Solis EC; Department of Psychiatry, Leiden University Medical Center, P.O. Box 9600, Leiden, 2300, RC, The Netherlands. .
Carlier IVE; Department of Psychiatry, Leiden University Medical Center, P.O. Box 9600, Leiden, 2300, RC, The Netherlands.
Kamminga NGA; Department of Psychiatry and Medical Psychology, Maastricht University Medical Center, Maastricht, The Netherlands.; Faculty of Health, Medicine and Life Sciences (MHeNs), Maastricht University, Maastricht, The Netherlands.
Giltay EJ; Department of Psychiatry, Leiden University Medical Center, P.O. Box 9600, Leiden, 2300, RC, The Netherlands.
van Hemert AM; Department of Psychiatry, Leiden University Medical Center, P.O. Box 9600, Leiden, 2300, RC, The Netherlands.
Pokaż więcej
Źródło:
Trials [Trials] 2024 Mar 13; Vol. 25 (1), pp. 187. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article; Multicenter Study; Pragmatic Clinical Trial; Randomized Controlled Trial
MeSH Terms:
Depressive Disorder, Treatment-Resistant*
Self-Management*
Adult ; Aged ; Humans ; Caregivers/psychology ; Chronic Disease ; Quality of Life ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anxious-depressive attack and rejection sensitivity-Toward a new approach to treatment-resistant depression.
Autorzy:
Kaiya H; Panic Disorder Research Center, Warakukai Medical Corporation, Tokyo, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2024 Mar; Vol. 44 (1), pp. 17-28. Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Depression*/psychology
Depressive Disorder, Treatment-Resistant*/drug therapy
Humans ; Anxiety/psychology ; Anxiety Disorders/psychology ; Receptors, Opioid/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Vagus Nerve Stimulation Modulates Inflammation in Treatment-Resistant Depression Patients: A Pilot Study.
Autorzy:
Lespérance P; Department of Psychiatry, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H2X 0C1, Canada.
Desbeaumes Jodoin V; Department of Psychiatry, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H2X 0C1, Canada.
Drouin D; Department of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.
Racicot F; Division of Neurosurgery, CHUM, Université de Montréal, Montreal, QC H2X 0C1, Canada.
Miron JP; Department of Psychiatry, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H2X 0C1, Canada.
Longpré-Poirier C; Department of Psychiatry, Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal, Montreal, QC H2X 0C1, Canada.
Fournier-Gosselin MP; Division of Neurosurgery, CHUM, Université de Montréal, Montreal, QC H2X 0C1, Canada.
Thebault P; Centre de Recherche du CHUM (CRCHUM), Institut du Cancer de Montréal, Montreal, QC H2X 0A9, Canada.
Lapointe R; Department of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.; Centre de Recherche du CHUM (CRCHUM), Institut du Cancer de Montréal, Montreal, QC H2X 0A9, Canada.
Arbour N; Department of Neurosciences, Université de Montréal and CRCHUM, Montreal, QC H2X 0A9, Canada.
Cailhier JF; Department of Medicine, Université de Montréal, Montreal, QC H3T 1J4, Canada.; Centre de Recherche du CHUM (CRCHUM), Institut du Cancer de Montréal, Montreal, QC H2X 0A9, Canada.; Department of Medicine, Renal Division, CHUM, Université de Montréal, Montreal, QC H2X 0C1, Canada.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 26; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:
Journal Article
MeSH Terms:
Vagus Nerve Stimulation*
Depressive Disorder, Treatment-Resistant*/psychology
Humans ; Pilot Projects ; Depression ; Treatment Outcome ; Inflammation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hippocampal volume changes after (R,S)-ketamine administration in patients with major depressive disorder and healthy volunteers.
Autorzy:
Evans JW; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Dr., Bldg 10, Rm 7-3335, Bethesda, MD, 20814, USA. .
Graves MC; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Dr., Bldg 10, Rm 7-3335, Bethesda, MD, 20814, USA.
Nugent AC; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Dr., Bldg 10, Rm 7-3335, Bethesda, MD, 20814, USA.; MEG Core, NIMH, Bethesda, MD, USA.
Zarate CA Jr; Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, 10 Center Dr., Bldg 10, Rm 7-3335, Bethesda, MD, 20814, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 24; Vol. 14 (1), pp. 4538. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Journal Article
MeSH Terms:
Depressive Disorder, Major*/diagnostic imaging
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Major*/pathology
Depressive Disorder, Treatment-Resistant*
Ketamine*/pharmacology
Ketamine*/therapeutic use
Humans ; Healthy Volunteers ; Hippocampus/pathology ; Treatment Outcome ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A randomized sham-controlled trial of high-dosage accelerated intermittent theta burst rTMS in major depression: study protocol.
Autorzy:
Goodman MS; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Vila-Rodriguez F; Non-Invasive Neurostimulation Therapies Laboratory, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada.
Barwick M; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.; The Hospital for Sick Children, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Burke MJ; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Brain Sciences Research Program, Sunnybrook Research Institute, Toronto, ON, Canada.
Downar J; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Hunter J; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Mount Sinai Hospital, Toronto, ON, Canada.
Kaster TS; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Knyahnytska Y; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Kurdyak P; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Canada.
Maunder R; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Mount Sinai Hospital, Toronto, ON, Canada.
Thorpe K; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.; Applied Health Research Centre, St. Michael's Hospital, Toronto, ON, Canada.
Trevizol AP; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Voineskos D; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
Zhang W; Centre for Advancing Health Outcomes, St Paul's Hospital, Vancouver, BC, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
Blumberger DM; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada. .; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2024 Jan 08; Vol. 24 (1), pp. 28. Date of Electronic Publication: 2024 Jan 08.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Depressive Disorder, Major*/therapy
Depressive Disorder, Treatment-Resistant*/therapy
Behavior, Addictive*
Humans ; Transcranial Magnetic Stimulation ; Depression ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Anesthetic Management of Patients Undergoing Electroconvulsive Therapy.
Autorzy:
Sebastian S; is Staff CRNA at the Department of Anesthesiology and Pain Management, University of Texas, Southwestern Medical Center, Dallas, Texas. Email: .
Pokaż więcej
Źródło:
AANA journal [AANA J] 2023 Dec; Vol. 91 (6), pp. 465-471.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Anesthetics*
Depressive Disorder, Treatment-Resistant*
Electroconvulsive Therapy*/methods
Humans ; Anesthesia, General/methods ; Seizures
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prospective study of antidepressant treatment of psychiatric patients with depressive disorders: treatment adequacy and outcomes.
Autorzy:
von Knorring J; Department of Psychiatry, University of Helsinki and Helsinki University Hospital, P.O. Box 22, Helsinki, FI-00014, Finland.
Baryshnikov I; Department of Psychiatry, University of Helsinki and Helsinki University Hospital, P.O. Box 22, Helsinki, FI-00014, Finland.
Jylhä P; Department of Psychiatry, University of Helsinki and Helsinki University Hospital, P.O. Box 22, Helsinki, FI-00014, Finland.
Talaslahti T; Department of Psychiatry, University of Helsinki and Helsinki University Hospital, P.O. Box 22, Helsinki, FI-00014, Finland.
Heikkinen M; Department of Psychiatry, University of Helsinki and Helsinki University Hospital, P.O. Box 22, Helsinki, FI-00014, Finland.
Isometsä E; Department of Psychiatry, University of Helsinki and Helsinki University Hospital, P.O. Box 22, Helsinki, FI-00014, Finland. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2023 Nov 28; Vol. 23 (1), pp. 888. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Major*/diagnosis
Depressive Disorder, Treatment-Resistant*/drug therapy
Humans ; Female ; Prospective Studies ; Antidepressive Agents/therapeutic use ; Treatment Outcome ; Psychotherapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis.
Autorzy:
Guerrera CS; Department of Educational Sciences, University of Catania, Catania, Italy.; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Platania GA; Department of Educational Sciences, University of Catania, Catania, Italy.
Boccaccio FM; Department of Educational Sciences, University of Catania, Catania, Italy.
Sarti P; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
Varrasi S; Department of Educational Sciences, University of Catania, Catania, Italy.
Colliva C; Azienda Unità Sanitaria Locale Di Modena, Distretto Di Carpi, Carpi, Italy.
Grasso M; Unit of Neuropharmacology and Translation Neurosciences, Oasi Research Institute - IRCCS, Troina, Italy.
De Vivo S; Villa dei Gerani Clinic ASP3 Catania, Catania, Italy.
Cavallaro D; Villa dei Gerani Clinic ASP3 Catania, Catania, Italy.
Tascedda F; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy.
Pirrone C; Department of Educational Sciences, University of Catania, Catania, Italy.
Drago F; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Di Nuovo S; Department of Educational Sciences, University of Catania, Catania, Italy.
Blom JMC; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy. .; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy. .
Caraci F; Unit of Neuropharmacology and Translation Neurosciences, Oasi Research Institute - IRCCS, Troina, Italy.; Department of Drug and Health Sciences, University of Catania, Catania, Italy.
Castellano S; Department of Educational Sciences, University of Catania, Catania, Italy.
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2023 Nov 28; Vol. 23 (1), pp. 885. Date of Electronic Publication: 2023 Nov 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Treatment-Resistant*/drug therapy
Humans ; Antidepressive Agents ; Selective Serotonin Reuptake Inhibitors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)-Phase II single-arm open-label feasibility study.
Autorzy:
Lee W; University of Technology Sydney, Ultimo, NSW, Australia.; St. Vincent Health Australia, Sydney, NSW, Australia.; HammondCare, Royal North Shore Hospital, St. Leonards, NSW, Australia.; University of Sydney, Northern Clinical School, St. Leonards, NSW, Australia.
Sheehan C; Calvary Hospital, Kogarah, NSW, Australia.
Chye R; University of Technology Sydney, Ultimo, NSW, Australia.; St. Vincent Health Australia, Sydney, NSW, Australia.; University of Notre Dame Australia, Fremantle, NSW, Australia.; University of New South Wales, Randwick, NSW, Australia.
Chang S; University of Technology Sydney, Ultimo, NSW, Australia.
Bayes A; University of New South Wales, Randwick, NSW, Australia.; Blackdog Institute, Hospital Road, Prince of Wales Hospital, Randwick, NSW, Australia.
Loo C; University of New South Wales, Randwick, NSW, Australia.; Blackdog Institute, Hospital Road, Prince of Wales Hospital, Randwick, NSW, Australia.
Draper B; University of New South Wales, Randwick, NSW, Australia.
Agar MR; University of Technology Sydney, Ultimo, NSW, Australia.; University of New South Wales, Randwick, NSW, Australia.
Currow DC; University of Wollongong, Wollongong, NSW, Australia.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 14; Vol. 18 (11), pp. e0290876. Date of Electronic Publication: 2023 Nov 14 (Print Publication: 2023).
Typ publikacji:
Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Ketamine*/therapeutic use
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Treatment-Resistant*/drug therapy
Adult ; Humans ; Adolescent ; Feasibility Studies ; Infusions, Intravenous ; Australia ; Antidepressive Agents/therapeutic use ; Infusions, Subcutaneous ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Major Depressive Disorder (MDD): A Systematic Review.
Autorzy:
Zelada MI; Escuela de Medicina, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
Garrido V; Escuela de Medicina, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
Liberona A; Escuela de Medicina, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
Jones N; Escuela de Medicina, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
Zúñiga K; Escuela de Medicina, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
Silva H; Clínica Psiquiátrica Universitaria, Hospital Clínico de la Universidad de Chile, Universidad de Chile, Santiago 8380453, Chile.; Departamento de Psiquiatría y Salud Mental Norte, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
Nieto RR; Clínica Psiquiátrica Universitaria, Hospital Clínico de la Universidad de Chile, Universidad de Chile, Santiago 8380453, Chile.; Departamento de Psiquiatría y Salud Mental Norte, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.; Departamento de Neurociencias, Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Sep 30; Vol. 24 (19). Date of Electronic Publication: 2023 Sep 30.
Typ publikacji:
Systematic Review; Journal Article; Review
MeSH Terms:
Depressive Disorder, Major*/diagnosis
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Major*/genetics
Depressive Disorder, Treatment-Resistant*
Humans ; Brain-Derived Neurotrophic Factor/genetics ; Brain-Derived Neurotrophic Factor/therapeutic use ; Biomarkers ; Polymorphism, Genetic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Reduced reward responsiveness in treatment resistant depression of middle-aged adults: Association with carotid artery stiffness and tetrahydrobiopterin.
Autorzy:
Barhwal KK; Department of Physiology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.
Parida B; Department of Physiology, Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, India.
Pattnaik J; Department of Psychiatry, Kalinga Institute of Medical Sciences (KIMS), Bhubaneswar, India.
Rowlo P; Department of Biomedical Sciences in Dentistry, Hebrew University of Jerusalem, Jerusalem, Israel.
Mahakud S; Department of Radiology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.
Patra S; Department of Psychiatry, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.
Rao BN; Department of Physiology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.
Mahapatra B; Norwegian Refugee Council, Amman, Jordan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Aug 31; Vol. 18 (8), pp. e0290784. Date of Electronic Publication: 2023 Aug 31 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Depressive Disorder, Treatment-Resistant*/drug therapy
Depressive Disorder, Major*/drug therapy
Middle Aged ; Humans ; Adult ; Ankle Brachial Index ; Carotid Intima-Media Thickness ; Longitudinal Studies ; Pulse Wave Analysis ; Carotid Artery, Common
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Serum soluble triggering receptor expressed on myeloid cells-2 was not altered by rTMS in patients with treatment-resistant depression.
Autorzy:
Tateishi H; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Matsushima J; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Kunitake H; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Imamura Y; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Kunitake Y; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Murakawa T; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Mawatari S; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Kojima R; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Fujii Y; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Kikuchi J; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Fukuchi J; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Sakemura Y; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Shiraishi T; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Nagahama C; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Maekawa T; Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Asami T; Department of Rehabilitation Medicine, Saga University Hospital, Saga, Japan.
Mizoguchi Y; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Monji A; Department of Psychiatry, Faculty of Medicine, Saga University, Saga, Japan.
Pokaż więcej
Źródło:
Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2023 Jun; Vol. 43 (2), pp. 222-227. Date of Electronic Publication: 2023 Mar 12.
Typ publikacji:
Journal Article
MeSH Terms:
Depressive Disorder, Treatment-Resistant*/psychology
Depressive Disorder, Treatment-Resistant*/therapy
Receptors, Immunologic*/blood
Receptors, Immunologic*/chemistry
Transcranial Magnetic Stimulation*
Female ; Humans ; Male ; Middle Aged ; Body Mass Index ; Cognition ; Depression/psychology ; Depression/therapy ; Longitudinal Studies ; Smoking
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis of randomized sham-controlled trials.
Autorzy:
Vida RG; Department of Pharmaceutics, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.
Sághy E; Center for Health Technology Assessment and Pharmacoeconomic Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.
Bella R; Center for Health Technology Assessment and Pharmacoeconomic Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.
Kovács S; Center for Health Technology Assessment and Pharmacoeconomic Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.
Erdősi D; Center for Health Technology Assessment and Pharmacoeconomic Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.
Józwiak-Hagymásy J; Center for Health Technology Assessment and Pharmacoeconomic Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.
Zemplényi A; Center for Health Technology Assessment and Pharmacoeconomic Research, Faculty of Pharmacy, University of Pécs, Pécs, Hungary.
Tényi T; Department of Psychiatry and Psychotherapy, Clinical Center, Medical School, University of Pécs, Pécs, Hungary.
Osváth P; Department of Psychiatry and Psychotherapy, Clinical Center, Medical School, University of Pécs, Pécs, Hungary.
Voros V; Department of Psychiatry and Psychotherapy, Clinical Center, Medical School, University of Pécs, Pécs, Hungary. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2023 Jul 27; Vol. 23 (1), pp. 545. Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Depressive Disorder, Major*/drug therapy
Depressive Disorder, Treatment-Resistant*/drug therapy
Humans ; Transcranial Magnetic Stimulation/methods ; Treatment Failure ; Antidepressive Agents/therapeutic use ; Treatment Outcome ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Maintenance repetitive transcranial magnetic stimulation (rTMS) therapy for treatment-resistant depression: a study protocol of a multisite, prospective, non-randomized longitudinal study.
Autorzy:
Yamazaki R; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Matsuda Y; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan.
Oba M; Department of Clinical Data Science, Clinical Research and Education Premotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan.
Oi H; Department of Clinical Data Science, Clinical Research and Education Premotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan.
Kito S; Department of Psychiatry, The Jikei University School of Medicine, Tokyo, Japan. .; Department of Psychiatry, National Center Hospital, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi-Machi, Kodaira-Shi, Tokyo, 1878551, Japan. .; Neuromodulation Therapy and Research Center, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2023 Jun 16; Vol. 23 (1), pp. 437. Date of Electronic Publication: 2023 Jun 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Depressive Disorder, Major*/diagnosis
Depressive Disorder, Treatment-Resistant*/drug therapy
Humans ; Transcranial Magnetic Stimulation/methods ; Depression/therapy ; Longitudinal Studies ; Prospective Studies ; Treatment Outcome ; Recurrence ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[The Value of Deep Brain Stimulation in Difficult-To-Treat and Treatment-Refractory Depression].
Autorzy:
Baumann-Vogel H; Klinik für Psychiatrie und Psychotherapie, Clienia Schlössli AG, Oetwil am See, Schweiz.; Klinik für Neurologie, Universitätsspital Zürich, Universität Zürich, Zürich, Schweiz.
Ineichen C; Klinik für Neurologie, Universitätsspital Zürich, Universität Zürich, Zürich, Schweiz.
Stieglitz L; Klinik für Neurochirurgie, Universitätsspital Zürich, Universität Zürich, Zürich, Schweiz.
Kawohl W; Klinik für Psychiatrie und Psychotherapie, Clienia Schlössli AG, Oetwil am See, Schweiz.; Klinik für Psychiatrie, Psychotherapie und Psychosomatik, Psychiatrische Universitätsklinik Zürich, Zürich, Schweiz.
Pokaż więcej
Transliterated Title:
Der Stellenwert der tiefen Hirnstimulation bei der schwer behandelbaren sowie therapierefraktären Depression.
Źródło:
Praxis [Praxis (Bern 1994)] 2023 Jun; Vol. 112 (7-8), pp. 413-418.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Deep Brain Stimulation*/methods
Depressive Disorder, Treatment-Resistant*/therapy
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Modeling the antidepressant treatment response to transcranial magnetic stimulation using an exponential decay function.
Autorzy:
Berlow YA; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA. yosef_.; VA RR&D Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, 830 Chalkstone Ave, Providence, RI, 02908, USA. yosef_.
Zandvakili A; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.; VA RR&D Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, 830 Chalkstone Ave, Providence, RI, 02908, USA.
Brennan MC; VA RR&D Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, 830 Chalkstone Ave, Providence, RI, 02908, USA.
Williams LM; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.; Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), Veterans Affairs Palo Alto Health Care System, Palo Alto, CA, USA.
Price LH; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.; Butler Hospital, Alpert Medical School of Brown University, Providence, RI, USA.
Philip NS; Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, RI, USA.; VA RR&D Center for Neurorestoration and Neurotechnology, Providence VA Medical Center, 830 Chalkstone Ave, Providence, RI, 02908, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 May 02; Vol. 13 (1), pp. 7138. Date of Electronic Publication: 2023 May 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Transcranial Magnetic Stimulation*/methods
Depressive Disorder, Treatment-Resistant*/drug therapy
Humans ; Treatment Outcome ; Antidepressive Agents/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Multiple serum anti-glutamate receptor antibody levels in clozapine-treated/naïve patients with treatment-resistant schizophrenia.
Autorzy:
He J; Department of Psychiatry, Sir Run-Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.
Li J; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.; Affiliated Wuhan Mental Health Center, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wei Y; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.; Department of Psychiatry, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
He Z; Department of Psychiatry, Sir Run-Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.; School of Mental Health, Wenzhou Medical University, Wenzhou, China.
Liu J; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.; Xiangya Nursing School of Central South University, Changsha, China.
Yuan N; Hunan Provincial Brain Hospital (The second people's Hospital of Hunan Province), Changsha, China.
Zhou R; The Ninth Hospital of Changsha, Changsha, China.
He X; The Ninth Hospital of Changsha, Changsha, China.
Ren H; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China.; Department of Psychiatry, Shandong Provincial Hospital, Shandong University, Jinan, China.
Gu L; RIKEN Center for Advanced Intelligence Project, Tokyo, Japan.; Research Center for Advanced Science and Technology (RCAST), University of Tokyo, Tokyo, Japan.
Liao Y; Department of Psychiatry, Sir Run-Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Chen X; Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha, China. .
Tang J; Department of Psychiatry, Sir Run-Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, China. .; Hunan Provincial Brain Hospital (The second people's Hospital of Hunan Province), Changsha, China. .; Zigong Mental Health Center, Zigong, China. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2024 Apr 02; Vol. 24 (1), pp. 248. Date of Electronic Publication: 2024 Apr 02.
Typ publikacji:
Journal Article
MeSH Terms:
Clozapine*/adverse effects
Schizophrenia*/drug therapy
Schizophrenia*/diagnosis
Antipsychotic Agents*/adverse effects
Humans ; Schizophrenia, Treatment-Resistant ; Receptors, Glutamate/therapeutic use ; Glutamic Acid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CLEAR - clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings.
Autorzy:
Casetta C; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. .; South London and Maudsley NHS Foundation Trust, London, UK. .
Santosh P; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; South London and Maudsley NHS Foundation Trust, London, UK.
Bayley R; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Bisson J; Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
Byford S; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Dixon C; Wonford House Hospital, Devon Partnership NHS Trust, Exeter, UK.
Drake RJ; Division of Psychology & Mental Health, University of Manchester, Manchester, UK.; Greater Manchester Mental Health NHS Foundation Trust, Manchester, UK.
Elvins R; Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Emsley R; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Fung N; Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Hayes D; South London and Maudsley NHS Foundation Trust, London, UK.
Howes O; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
James A; Department of Psychiatry, University of Oxford, Oxford, UK.
James K; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Jones R; Birmingham and Solihull Mental Health Foundation Trust, Birmingham, UK.
Killaspy H; Division of Psychiatry, University College London, London, UK.
Lennox B; Department of Psychiatry, University of Oxford, Oxford, UK.
Marchant L; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
McGuire P; Department of Psychiatry, University of Oxford, Oxford, UK.
Oloyede E; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; South London and Maudsley NHS Foundation Trust, London, UK.
Rogdaki M; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; South London and Maudsley NHS Foundation Trust, London, UK.
Upthegrove R; Institute for Mental Health, University of Birmingham, Birmingham, UK.; Birmingham Early Intervention Service, Birmingham Womens and Childrens NHS Foundation Trust, Birmingham, UK.
Walters J; Division of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
Egerton A; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
MacCabe JH; Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.; South London and Maudsley NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2024 Feb 14; Vol. 24 (1), pp. 122. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Antipsychotic Agents*/adverse effects
Clozapine*/adverse effects
Schizophrenia*/therapy
Psychotic Disorders*/drug therapy
Child ; Humans ; Adolescent ; Aged ; Adult ; Young Adult ; Schizophrenia, Treatment-Resistant ; Quality of Life ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acute effects of lithium augmentation on the kidney in geriatric compared with non-geriatric patients with treatment-resistant depression.
Autorzy:
Osterland SL; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Adli M; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Psychiatry and Psychotherapy, Fliedner Klinik Berlin, Berlin, Germany.
Saritas T; Division of Nephrology and Clinical Immunology, University Hospital RWTH Aachen, Aachen, Germany.; University Hospital RWTH Aachen, Institute of Experimental Medicine and Systems Biology, Aachen, Germany.
Schlattmann P; Department of Statistics, Informatics and Data Sciences, Jena University Hospital, Jena, Germany.
Behr J; Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.; Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany.; Research Department of Experimental and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Müller-Mertel R; Department of Psychology - Clinical Psychology and Psychotherapy, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
Hoffmann K; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Stamm TJ; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Psychology - Clinical Psychology and Psychotherapy, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
Bschor T; Department of Psychiatry and Psychotherapy, Technical University of Dresden Medical School, Dresden, Germany.
Richter C; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Psychiatry and Psychotherapy, Vivantes Klinikum Kaulsdorf, Berlin, Germany.
Steinacher B; Department of Psychiatry and Psychotherapy, Vivantes Wenckebach-Klinikum, Berlin, Germany.; Department of Psychiatry and Psychotherapy, Vivantes Auguste-Viktoria-Klinikum, Berlin, Germany.
Jockers-Scherübl MC; Department of Psychiatry, Oberhavel Kliniken, Hennigsdorf, Germany.
Köhler S; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Heinz A; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ricken R; Department of Psychiatry and Psychotherapy, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Buspavanich P; Department of Psychiatry, Psychotherapy and Psychosomatics, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.; Faculty of Health Sciences Brandenburg, Joint Faculty of the University of Potsdam, Brandenburg University of Technology Cottbus-Senftenberg and Brandenburg Medical School, Potsdam, Germany.; Research Unit Gender in Medicine, Department of Psychiatry and Psychotherapy, Institute of Sexology and Sexual Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
Acta psychiatrica Scandinavica [Acta Psychiatr Scand] 2023 Mar; Vol. 147 (3), pp. 267-275. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Depressive Disorder, Treatment-Resistant*/drug therapy
Acute Kidney Injury*/chemically induced
Acute Kidney Injury*/drug therapy
Humans ; Aged ; Lithium/therapeutic use ; Depression ; Cohort Studies ; Prospective Studies ; Kidney
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 8977

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies